The introduction of nicotinamide as being a nicotine alternative in e-cigarette and smokeless solutions signifies a substantial regulatory obstacle for the FDA. Nicotinamide doesn't have nicotinic receptor agonist exercise and is known to act as a sedative at significant dosages6. The statements produced by Nicotine River, ECBlend, as well as other